Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1983
Viral nucleic acid synthesis and antigen accumulation in pancreas and kidney of Pekin ducks infected with duck hepatitis B virusM S Halpern, J M England, D T Deery, et al.
The Annals of Thoracic Surgery|December 10, 1999
Oncolytic therapy using a mutant type-1 herpes simplex virus and the role of the immune systemE S Lambright, D J Caparrelli, A E Abbas, et al.
Journal of Virology|February 1, 1988
Distinctive properties of the hepatitis B virus envelope proteinsK L Molnar-Kimber, V Jarocki-Witek, S K Dheer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 6, 2000
Effect of preexisting anti-herpes immunity on the efficacy of herpes simplex viral therapy in a murine intraperitoneal tumor modelE S Lambright, E H Kang, S Force, et al.
Cancer Gene Therapy|April 19, 2000
Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapyG Coukos, A Makrigiannakis, S Montas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancerG Coukos, A Makrigiannakis, E H Kang, et al.
Biochemical and Biophysical Research Communications|August 30, 1994
A putative sirolimus (rapamycin) effector proteinY Chen, H Chen, A E Rhoad, et al.
Virology|April 1, 1990
High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinantsP K Chanda, R J Natuk, B B Mason, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1990
Adenovirus vaccine strains genetically engineered to express HIV-1 or HBV antigens for use as live recombinant vaccinesP P Hung, P K Chanda, R J Natuk, et al.
Human Gene Therapy|October 6, 1998
Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesotheliomaK L Molnar-Kimber, D H Sterman, M Chang, et al.
Pageof 3